This review summarizes two main groups of natural compounds, covering diverse structural alkaloids and flavonoids with anticancer properties and their possible mechanisms are reviewed relying on the down-regulation of the Akt/mTOR pathway in lung cancer cells. The gene discussed is MTOR; the disease is lung carcinoma.